SWITCHING FROM ONABOTULINUMTOXIN-A TO ABOBOTULINUMTOXIN-A IN CHILDREN WITH CEREBRAL PALSY TREATED FOR SPASTICITY: A RETROSPECTIVE SAFETY AND EFFICACY EVALUATION

DURSUN, NİGAR; Akarsu, Melike; GÖKBEL, TUĞBA; Akyuz, MERVE; KARACAN, ÇAĞLA; DURSUN, ERBİL

doi:10.2340/16501977-2550

SWITCHING FROM ONABOTULINUMTOXIN-A TO ABOBOTULINUMTOXIN-A IN CHILDREN WITH CEREBRAL PALSY TREATED FOR SPASTICITY: A RETROSPECTIVE SAFETY AND EFFICACY EVALUATION

DURSUN N., Akarsu M., GÖKBEL T., Akyuz M., KARACAN Ç., DURSUN E.

JOURNAL OF REHABILITATION MEDICINE, cilt.51, sa.5, ss.390-394, 2019 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 51 Sayı: 5
Basım Tarihi: 2019
Doi Numarası: 10.2340/16501977-2550
Dergi Adı: JOURNAL OF REHABILITATION MEDICINE
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.390-394
Anahtar Kelimeler: botulinum toxin, cerebral palsy, spasticity, abobotulinumtoxin-A, onabotulinumtoxin-A, Dysport, Botox, BOTULINUM-TOXIN-A, ADOLESCENTS
Kocaeli Üniversitesi Adresli: Evet

Özet

Objectives: To determine whether switching from onabotulinumtoxin-A to abobotulinumtoxin-A in children with cerebral palsy is safe and whether therapeutic efficacy is maintained.